Shimadzu expands mammography efforts

Article

Shimadzu Medical Systems officially moved into the global mammography market at the RSNA show when it signed a nonexclusive distribution and marketing agreement with Planmed. According to terms of the deal, Wood Dale, IL-based Planmed’s Sophie and

Shimadzu Medical Systems officially moved into the global mammography market at the RSNA show when it signed a nonexclusive distribution and marketing agreement with Planmed. According to terms of the deal, Wood Dale, IL-based Planmed’s Sophie and Sophie Classic product line will be sold worldwide under Shimadzu’s own name. The agreement expands a partnership established in 1995 between Planmed and Shimadzu Corporation, which allows Shimadzu to market Planmed’s mammography products in Japan under the trade name Sepio. The new agreement extends Shimadzu’s distribution of Planmed mammography products to North and South America, Europe, and Australia.

The deal allows Shimadzu to fill out its product portfolio and target larger strategic accounts such as group purchasing and veterans organizations and hospital networks, according to Don Karle, director of sales and marketing for North America. The Torrance, CA-based firm plans to sell between 30 and 50 mammography units in 2000, Karle said.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.